TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - NOVARTIS N Stock

Certificat

DE000CJ5HZQ3

Market Closed - Börse Stuttgart 03:45:31 2024-04-26 EDT
4.51 EUR -2.38% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - NOVARTIS N
Current month+5.87%
1 month+8.15%
Date Price Change Volume
24-04-26 4.51 -2.38% 0
24-04-25 4.62 +2.67% 0
24-04-24 4.5 -4.66% 0
24-04-23 4.72 +14.01% 0
24-04-22 4.14 +3.24% 0

Delayed Quote Börse Stuttgart

Last update April 26, 2024 at 03:45 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Société Générale Société Générale
WKN CJ5HZQ
ISINDE000CJ5HZQ3
Date issued 2018-11-05
Strike 45.75 CHF
Maturity Unlimited
Parity 10 : 1
Emission price 2.49
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5
Lowest since issue 1.78

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
97.84 USD
Average target price
108.5 USD
Spread / Average Target
+10.88%
Consensus